Last $9.59 USD
Change Today -0.45 / -4.48%
Volume 312.5K
PETX On Other Exchanges
Symbol
Exchange
NASDAQ GM
Stuttgart
As of 8:10 PM 10/1/14 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Steven St. Peter M.D.

Co-Founder, Chief Executive Officer, President and Director, Aratana Therapeutics, Inc.
AgeTotal Calculated CompensationThis person is connected to 54 board members in 6 different organizations across 14 different industries.

See Board Relationships
48$1,172,390
As of Fiscal Year 2013

Background*

Dr. Steven St. Peter, M.D., is a Co-Founder of Aratana Therapeutics, Inc., and has been its Chief Executive Officer and President since September 6, 2012. Dr. St. Peter served as the Managing Director of MPM Capital until May 2012, which he joined MPM Capital in 2003. He started working at the MPM in 2004 and was promoted to a General Partner in 2005. He served as a Principal of the MPM. His investment scope included both venture and buyout transactions across the pharmaceuticals ...

Read Full Background

Corporate Headquarters*

1901 Olathe Boulevard
Kansas City, Kansas 66103

United States

Phone: 913-951-2132
Fax: --

Board Members Memberships*

Former Director and Member of Nominating & Corporate Governance Committee
Director
Former Chief Executive Officer, President, Chief Financial Officer and Director
Director
Former Director
Former Principal Executive Officer, President, Principal Financial Officer and Director
Director
2004-N/A
Director and Member of Governance & Nominating Committee
2005-N/A
Former Director and Chairman of Compensation Committee
2007-Present
Independent Director and Member of Governance & Nominating Committee
2007-2008
Former Director and Member of Nominating & Corporate Governance Committee
2008-N/A
Director
2010-Present
Co-Founder, Chief Executive Officer, President and Director

Education*

MD
Washington University, St. Louis
BA
University of Kansas
MBA
University of Pennsylvania - The Wharton School

Other Affiliations*

Annual Compensation*

Salary$425,000
Total Annual Compensation$425,000

Stock Options*

All Other Compensation$13,725
Unexercisable Options150,421
Unexercisable Options Value$1,970,515
Total Value of Options$1,970,515
Total Number of Options150,421

Total Compensation*

Total Annual Cash Compensation$619,350
Total Short Term Compensation$425,000
Other Long Term Compensation$13,725
Total Calculated Compensation$1,172,390
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
PETX:US $9.59 USD -0.45

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Richard Chin M.D.Co-Founder, Chief Executive Officer, President, Director and Member of Nominating & Corporate Governance Committee
Kindred Biosciences, Inc.
$486.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ARATANA THERAPEUTICS INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.